Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

Acne Infection

Acne Infection

Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...

Inflammatory Bowel Disease IV: Pharmacological Management

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...

Peripheral Artery Disease IV: Nursing Management

Peripheral Artery Disease IV: Nursing Management

The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses, temperature changes,...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Antiphospholipid antibodies in acute and post-treatment Lyme disease.

Infection and immunity·2026

Same author

Protective efficacy of mutant strains of <i>Borrelia burgdorferi</i> as potential reservoir host-targeted biologics against Lyme disease.

Infection and immunity·2026

Same author

Evaluation of standard and modified two-tiered testing algorithms using well-characterized early Lyme disease samples.

Journal of clinical microbiology·2026

Same author

Beyond the burden: Measuring the quality of life impact of Parkinson's on family members/partners using FROM-16.

Journal of Parkinson's disease·2026

Same author

The Use of Artificial Intelligence in Dermatology Systematic Reviews: A Comparative Analysis of Elicit Against Human Reviewers.

Acta dermato-venereologica·2026

Same author

Confirmation of unidimensionality of the Dermatology Life Quality Index (DLQI) using a multinational 3,408 patient dataset.

Journal of patient-reported outcomes·2026

Search research articles

Related Experiment Video

Updated: Jun 29, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

Psoriasis: improving adherence to topical therapy.

Steven R Feldman¹, Elizabeth J Horn, Rajesh Balkrishnan

¹Center for Dermatology Research, Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.

Journal of the American Academy of Dermatology

|October 7, 2008

Summary

This summary is machine-generated.

Improving topical psoriasis treatment outcomes requires addressing patient adherence. A new model by the International Psoriasis Council Topical Therapy Working Group helps healthcare providers encourage better medication use for improved psoriasis control.

More Related Videos

Measuring Psoriasis Severity at Home

Measuring Psoriasis Severity at Home

Published on: March 1, 2024

Related Experiment Videos

Last Updated: Jun 29, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

Measuring Psoriasis Severity at Home

Measuring Psoriasis Severity at Home

Published on: March 1, 2024

Area of Science:

Dermatology
Pharmacology
Patient Adherence Research

Background:

Topical therapy is a cornerstone in psoriasis management, known for efficacy and safety.
Suboptimal outcomes in topical psoriasis treatment are frequently linked to poor patient adherence and incorrect medication application.

Purpose of the Study:

To present a novel model developed by the International Psoriasis Council Topical Therapy Working Group.
To elucidate the complex interplay between patient, disease, and treatment factors influencing adherence and outcomes.
To provide actionable recommendations for healthcare providers to enhance patient adherence to topical psoriasis therapies.

Main Methods:

Development of a conceptual model integrating patient, disease, and treatment characteristics.
Analysis of factors contributing to adherence behavior in topical psoriasis treatment.
Formulation of evidence-based recommendations for clinical practice.

Main Results:

A comprehensive model illustrating the multifaceted nature of topical therapy adherence in psoriasis.
Identification of key factors influencing patient adherence and treatment effectiveness.
Evidence-based strategies to improve adherence and optimize treatment outcomes.

Conclusions:

Enhancing patient adherence is critical for maximizing the effectiveness of topical psoriasis treatments.
The proposed model offers a framework for understanding and addressing adherence barriers.
Healthcare providers can leverage these recommendations to improve patient outcomes in psoriasis management.